MY116202A - Carbapenem antibiotic, composition and method of preparation - Google Patents
Carbapenem antibiotic, composition and method of preparationInfo
- Publication number
- MY116202A MY116202A MYPI97002165A MYPI19972165A MY116202A MY 116202 A MY116202 A MY 116202A MY PI97002165 A MYPI97002165 A MY PI97002165A MY PI19972165 A MYPI19972165 A MY PI19972165A MY 116202 A MY116202 A MY 116202A
- Authority
- MY
- Malaysia
- Prior art keywords
- composition
- preparation
- carbapenem antibiotic
- thereoft
- prodrug
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
A PHANNACEUTICAL COMPOSITION IS DISCLOSED WHICH CONTAINS A COMPOUND OF FORMULA I: OR A PHARMACEUTICALLY ACCEPTABLE SALT, PRODRUG OR HYDRATE THEREOFT IN THE STABILIZED FORM AND/OR IN COMBINATION WITH A CARBON DIOXIDE SOURCE.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1851896P | 1996-05-28 | 1996-05-28 | |
GBGB9612668.5A GB9612668D0 (en) | 1996-06-18 | 1996-06-18 | Carbapenem antibiotic composition and method of preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
MY116202A true MY116202A (en) | 2003-11-28 |
Family
ID=10795438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI97002165A MY116202A (en) | 1996-05-28 | 1997-05-19 | Carbapenem antibiotic, composition and method of preparation |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR006284A1 (en) |
BR (1) | BR9702231B8 (en) |
GB (1) | GB9612668D0 (en) |
MY (1) | MY116202A (en) |
-
1996
- 1996-06-18 GB GBGB9612668.5A patent/GB9612668D0/en active Pending
-
1997
- 1997-05-19 AR ARP970102114A patent/AR006284A1/en unknown
- 1997-05-19 MY MYPI97002165A patent/MY116202A/en unknown
- 1997-05-23 BR BRPI9702231A patent/BR9702231B8/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
BR9702231A (en) | 1999-02-23 |
GB9612668D0 (en) | 1996-08-21 |
BR9702231B1 (en) | 2019-03-12 |
BR9702231B8 (en) | 2022-01-18 |
AR006284A1 (en) | 1999-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1016176A1 (en) | Carbapenem antibiotic, composition and method of preparation | |
MY132671A (en) | Substituted 6,6-hetero-bicyclic derivatives | |
AU3215597A (en) | Method of inhibiting fibrosis with a somatostatin agonist | |
AU6645998A (en) | Oxygen or sulfur containing heteroaromatics as factor xa inhibitors | |
AU6114699A (en) | Naphthrydine compounds and their azaisosteric analogues as antibacterials | |
NZ333385A (en) | Solid oral dosage forms containing 35% of valsartan | |
MX9804046A (en) | 6-0-methyl erythromycin d and process for making. | |
AU8156394A (en) | Methods for inhibiting LDL oxidation and atheroclerosis | |
ZA974573B (en) | Carbapenem antibiotic, composition and method of preparation. | |
AU5727899A (en) | Diaminocyclobutene-3,4-dione derivatives, their preparation and use | |
WO1998027930A3 (en) | New use of aminopiperazine derivatives | |
MY133169A (en) | Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect | |
MY116202A (en) | Carbapenem antibiotic, composition and method of preparation | |
GB2333294A (en) | Cytokine production inhibitors | |
ECSP972136A (en) | COMPOSITION AND METHOD OF PREPARATION OF A CARBAPEMEN ANTIBIOTIC | |
EP0937718A4 (en) | Antibiotic tkr2648 and process for producing the same | |
EP0918058A4 (en) | Dc 107 derivatives (1) | |
AU5932394A (en) | New compound, leustroducsin H, its preparation and its therapeutic use |